Role of eukaryotic translation initiation factor 3a in bleomycin-induced pulmonary fibrosis

European Journal of Pharmacology

Volumn 749, Issue , 2015, Pages 89-97

  Li, Xian Wei ^a,b   Wu, Yue Han ^a   Li, Xiao Hui ^a   Li, Dai ^c   Du, Jie ^a   Hu, Chang Ping ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b WANNAN MEDICAL COLLEGE   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ERK1 2; Eukaryotic translation initiation factor 3a; Pulmonary fibroblasts; Pulmonary fibrosis; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; EUKARYOTIC TRANSLATION INITIATION FACTOR 3A; INITIATION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; COLLAGEN; INITIATION FACTOR 3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; LUNG FIBROBLAST; MALE; MORPHOLOGY; MYOFIBROBLAST; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; LUNG; LUNG FIBROSIS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; COLLAGEN; EUKARYOTIC INITIATION FACTOR-3; LUNG; MALE; MAP KINASE SIGNALING SYSTEM; PULMONARY FIBROSIS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84921691444     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.01.004     Document Type: Article

References (40)

1. T. Ashcroft, J.M. Simpson, and V. Timbrell Simple method of estimating severity of pulmonary fibrosis on a numerical scale J. Clin. Pathol. 41 1988 467 470
2. P. Bonniaud, P.J. Margetts, M. Kolb, T. Haberberger, M. Kelly, J. Robertson, and J. Gauldie Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis Am. J. Respir. Crit. Care Med. 168 2003 770 778
3. P. Bonniaud, P.J. Margetts, M. Kolb, J.A. Schroeder, A.M. Kapoun, D. Damm, A. Murphy, S. Chakravarty, S. Dugar, L. Higgins, A.A. Protter, and J. Gauldie Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor Am. J. Respir. Crit. Care Med. 171 2005 889 898
4. W.A. Border, and N.A. Noble Transforming growth factor beta in tissue fibrosis N. Engl. J. Med. 331 1994 1286 1292
5. G. Bou-Gharios, C.M. Black, C.P. Denton, D.J. Abraham, A. Leask, and G.E. Lindahl Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen Arthritis Rheumatol. 60 2009 2142 2155
6. R.K. Coker, G.J. Laurent, P.K. Jeffery, R.M. du Bois, C.M. Black, and R.J. Mc-Anulty Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung Thorax 56 2001 549 556
7. D.N. Cook, D.M. Brass, and D.A. Schwartz A matrix for new ideas in pulmonary fibrosis Am. J. Respir. Cell Mol. Biol. 27 2002 122 124
8. E. Damoc, C.S. Fraser, M. Zhou, H. Videler, G.L. Mayeur, J.W. Hershey, J.A. Doudna, C.V. Robinson, and J.A. Leary Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry Mol. Cell. Proteomics 6 2007 1135 1146
9. M.I. Dobrikov, E.Y. Dobrikova, and M. Gromeier Dynamic regulation of the translation initiation helicase complex by mitogenic signal transduction to eukaryotic translation initiation factor 4G Mol. Cell. Biol. 33 2013 937 946
10. Z. Dong, L.H. Liu, B. Han, R. Pincheira, and J.T. Zhang Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth Oncogene 23 2004 3790 3801
11. Z. Dong, Z. Liu, P. Cui, R. Pincheira, Y. Yang, J. Liu, and J.T. Zhang Role of eIF3a in regulating cell cycle progression Exp. Cell Res. 315 2009 1889 1894
12. Z. Dong, and J.T. Zhang Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer Crit. Rev. Oncol. Hematol. 59 2006 169 180
13. M. Galuppo, E. Esposito, E. Mazzon, R. Di Paola, I. Paterniti, D. Impellizzeri, and S. Cuzzocrea MEK inhibition suppresses the development of lung fibrosis in the bleomycin model Naunyn Schmiedebergs Arch. Pharmacol. 384 2011 21 37
14. T.J. Gross, and G.W. Hunninghake Idiopathic pulmonary fibrosis N. Engl. J. Med. 345 2001 517 525
15. L. Gu, Y.J. Zhu, X. Yang, Z.J. Guo, W.B. Xu, and X.L. Tian Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation Acta Pharmacol. Sin. 28 2007 382 391
16. S. Hashimoto, Y. Gon, I. Takeshita, K. Matsumoto, S. Maruoka, and T. Horie Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway Am. J. Respir. Crit. Care Med. 163 2001 152 157
17. B. Hinz, S.H. Phan, V.J. Thannickal, A. Galli, M.L. Bochaton-Piallat, and G. Gabbiani The myofibroblast: one function, multiple origins Am. J. Pathol. 170 2007 1807 1816
18. H.D. Jiang, and H.S. Guan MS80, a novel sulfated oligosaccharide, inhibits pulmonary fibrosis by targeting TGF-beta1 both in vitro and in vivo Acta Pharmacol. Sin. 30 2009 973 979
19. H.R. Kang, S.J. Cho, C.G. Lee, R.J. Homer, and J.A. Elias Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12 J. Biol. Chem. 282 2007 7723 7732
20. A.L. Katzenstein, D.A. Zisman, L.A. Litzky, B.T. Nguyen, and R.M. Kotloff Usual interstitial pneumonia: histologic study of biopsy and explant specimens Am. J. Surg. Pathol. 26 2002 1567 1577
21. S. Kazemi, Z. Mounir, D. Baltzis, J.F. Raven, S. Wang, J.L. Krishnamoorthy, O. Pluquet, J. Pelletier, and A.E. Koromilas A novel functions of eIF2 alpha kinases as inducers of the phosphoinositide-3 kinase signaling pathway Mol. Biol. Cell 18 2007 3635 3644
22. N. Khalil, T.V. Parekh, R. O'Connor, N. Antman, W. Kepron, T. Yehaulaeshet, Y.D. Xu, and L.I. Gold Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis Thorax 56 2001 907 915
23. X.W. Li, C.P. Hu, W.H. Wu, W.F. Zhang, X.Z. Zou, and Y.J. Li Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27 Eur. J. Pharmacol. 679 2012 117 126
24. U. Maitra, E.A. Stringer, and A. Chaudhuri Initiation factors in protein biosynthesis Annu. Rev. Biochem. 51 1982 869 900
25. S.H. Phan The myofibroblast in pulmonary fibrosis Chest 122 2002 286S 289S
26. M. Ponticos, A.M. Holmes, X. Shi-wen, P. Leoni, K. Khan, V.S. Rajkumar, R.K. Hoyles, L.F. Li, S.K. Liao, C.C. Huang, M.J. Hung, and D.A. Quinn Serine/threonine kinase-protein kinase B and extracellular signal-regulated kinase regulate ventilator-induced pulmonary fibrosis after bleomycin-induced acute lung injury: a prospective, controlled animal experiment Crit. Care 12 2008 R103
27. F. Saletta, Y.S Rahmanto, and D.R. Richardson The translational regulator eIF3a: the tricky eIF3 subunit! Biochim. Biophys. Acta 1806 2010 275 286
28. C.J. Scotton, and R.C. Chambers Molecular targets in pulmonary fibrosis: the myofibroblast in focus Chest 132 2007 1311 1321
29. A. Serrano-Mollar, D. Closa, N. Prats, S. Blesa, M. Martinez-Losa, J. Cortijo, J.M. Estrela, E.J. Morcillo, and O. Bulbena In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats Br. J. Pharmacol. 138 2003 1037 1048
30. J. Shen, J.Y. Yin, X.P. Li, Z.Q. Liu, Y. Wang, J. Chen, J. Qu, X.J. Xu, H.L. McLeod, Y.J. He, K. Xia, Y.W. Jia, and H.H. Zhou The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers PLoS One 9 2014 e96008
31. Y. Shi, and J. Massagué Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 2003 685 700
32. P.J. Sime, Z. Xing, F.L. Graham, K.G. Csaky, and J. Gauldie Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung J. Clin. Invest. 100 1997 768 776
33. M.S. Wilson, and T.A. Wynn Pulmonary fibrosis: pathogenesis, etiology and regulation Mucosal Immunol. 2 2009 103 121
34. K.M. Wylie, J.E. Schrimpf, and L.A. Morrison Increased eIF 2alphaphosphorylation attenuates replication of herpes simplex virus 2 vhs mutants in mouse embryonic fibroblasts and correlates with reduced accumulation of the PKR antagonist ICP34.5 J. Virol. 83 2009 9151 9162
35. T.A. Wynn Integrating mechanisms of pulmonary fibrosis J. Exp. Med. 208 2011 1339 1350
36. J. Xu, S. Lamouille, and R. Derynck TGF-beta-induced epithelial to mesenchymal transition Cell Res. 19 2009 156 172
37. J.Y. Yin, J. Shen, Z.Z. Dong, Q. Huang, M.Z. Zhong, D.Y. Feng, H.H. Zhou, J.T. Zhang, and Z.Q. Liu Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair Clin. Cancer Res. 17 2011 4600 4609
38. K. Yoshida, K. Kuwano, N. Hagimoto, K. Watanabe, T. Matsuba, M. Fujita, I. Inoshima, and N. Hara MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis J. Pathol. 198 2002 388 396
39. H. Zhang, X. Liu, S. Chen, J. Wu, X. Ye, L. Xu, H. Chen, D. Zhang, R. Tan, and Y. Wang Tectorigenin inhibits the in vitro proliferation and enhances miR-338 expression of pulmonary fibroblasts in rats with idiopathic pulmonary fibrosis J. Ethnopharmacol. 131 2010 165 173
40. L. Zhang, X. Pan, and J.W. Hershey Individual over expression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells J. Biol. Chem. 282 2007 5790 5800